Geron Stock (NASDAQ: GERN) stock price, news, charts, stock research, profile.
Open | $3.500 |
Close | $3.550 |
Volume / Avg. | 10.703M / 12.758M |
Day Range | 3.500 - 3.660 |
52 Wk Range | 1.640 - 4.300 |
Market Cap | $2.106B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 9.14% |
Days to Cover | 7.02 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Geron (NASDAQ: GERN) through any online brokerage.
Other companies in Geron’s space includes: Twist Bioscience (NASDAQ:TWST), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN), Agios Pharmaceuticals (NASDAQ:AGIO) and Novavax (NASDAQ:NVAX).
The latest price target for Geron (NASDAQ: GERN) was reported by Needham on Thursday, May 2, 2024. The analyst firm set a price target for 5.00 expecting GERN to rise to within 12 months (a possible 40.85% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Geron (NASDAQ: GERN) is $3.55 last updated May 31, 2024 at 4:38 PM EDT.
There are no upcoming dividends for Geron.
Geron’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Geron.
Geron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.